BullishMEDIUM severityHealthcare & Pharma67d ago

Jim Cramer Calls Medtronic (MDT) a “Quandary” as Growth Surges and Diabetes Exit Nears

Jim Cramer Calls Medtronic (MDT) a “Quandary” as Growth Surges and Diabetes Exit Nears — $MDT one-month chart
$MDT daily closes over the past month · Wook of Wall Street artwork from market data

At a glance

WOOKAI ASSISTANTREADY
WOOK AIASK ANYTHING · NEVER ADVISES

Ask about MDT. Get explanations, comparisons and calculations with the source lookups shown.

Risk check · MedtronicEvent risk Moderate
  • Key person: Filed with SEC
  • Clear: legal, regulatory, security, operational, financial integrity
From here · options-implied volatility 30% a year
Now $102.88Week $98.56–$107.20 (±4.2%)Month $94.02–$111.74 (±8.6%)

Options price an average move of ±7.0% by Dec 18 — the at-the-money straddle, the typical size of the move; the bands are one standard deviation.

Early signals (1) — filed with the SEC or first reported, not yet widely covered
  • Key person · SEC 8-K, Item 5.02, Oct 19: Filed: a director or officer departed, was appointed, or had their pay changed. View filing →
Ask Wook AI

Close-to-close moves; beta-adjusted against the S&P 500, σ in the stock’s own daily noise; ranges one standard deviation. Reports are outlets’ words or SEC filings. Not a forecast or advice.

Wook analysis

What it means

Key points
  • What to watch: Approvals and strong trial data can reprice a drugmaker quickly — especially when one product is most of the company.
  • How the stock is trading: $MDT +0.02% in the latest session.
  • Timing: It was published before the opening bell, so the next session was the first chance to trade on it.

Where the stock stands

Medtronic plc. ($MDT) edged up 0.02% to $102.88 in the latest session. Over the past month it is up 10.9%. That leaves it 3.2% below its 52-week high of $106.33 and 40% above its low of $73.31. Its range over the year spans 45%, which is moderate.

What the filings say

In its latest report (10-Q, filed Sep 3, 2026), $MDT earned $1.47B over the quarter to Jul 31, 2026 on revenue of $9.76B. Operations brought in $1.79B of cash over the quarter to Jul 31, 2026; after capital spending, free cash flow was $1.29B. Total liabilities were $42.46B against $1.69B of cash on Jul 31, 2026. Its most recent filings before this story: 10-Q on Sep 3, 2026, 8-K on Sep 1, 2026, 10-K on Jun 18, 2026. Figures are as filed with the SEC; the $MDT page has the full statements.

How much coverage it is getting

Nothing new on Medtronic plc. has come through Wook's feeds in the last 30 days, so this is still the most recent story on it.

The bigger picture

Healthcare stories turn on approvals, trial data and pricing: one FDA decision or trial readout can swing a single drugmaker hard, while drug-pricing policy moves the whole group at once. Health Care reads calm on Wook's supply-chain scanner today, with no unusual stress in the filings and disclosures it watches.

Coming up

$MDT earnings in 8 days — on the calendar well before this story broke. Fresh numbers are close.

What to watch next

The company's own filings are the primary source. Its latest SEC reports, including any filing on a material event, are on the $MDT page, and they say what management has disclosed without a reporter in between. Reading how two or three outlets frame the same story is the quickest way to separate the facts from the angle. Wook AI, at the top of the page, can work out how far $MDT is from its high or compare this week's coverage with earlier weeks.

Discussion

No one has weighed in yet. Start the discussion on this story.

What happened after this published

Yahoo Finance published this on September 10, 2026. $MDT has moved +12.29% ($91.62 to $102.88). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.

Headline and link are attributed to Yahoo Finance. Wook of Wall Street is an independent research tool and is not affiliated with Yahoo Finance. Nothing here is financial advice or a recommendation — research and educational content only.

Choose what Wook may measure. Essential sign-in and security cookies stay on.

Read the privacy policy